Healthcare & Medical Devices Global On demand · 24-48h

Global Adult Artificial Heart Market Strategic Research Report

Global Adult Artificial Heart Market Strategic Research Repo…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Adult Artificial Heart Market
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Total Artificial Heart, Left Ventricular Assist Device, Right Ventricular Assist Device, Biventricular Assist Device

By Application: Heart Transplant Goals, Heart Transplant Bridges, Others

Key Players: Abbott, SynCardia, Berlin Heart, Jarvik Heart, CARMAT, BiVACOR, Cleveland Heart, Abiomed, CorWave, Suzhou Tongxin Medical Equipment Co, Thoratec Corporation, Medtronic, Evaheart, Inc, CardioDyme

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2024 · forecast to 2032
Length: 125 pages

Обзор

Scope of the Report

An adult artificial heart is a medical device that is designed to replace a damaged or diseased heart in an adult patient. It is used as a last resort treatment option for individuals who have end-stage heart failure and are not eligible for a heart transplant. The artificial heart is typically made up of two ventricles, which are responsible for pumping blood throughout the body. These ventricles are connected to an external power source and control unit, which help regulate the pumping action of the artificial heart. The main goal of an adult artificial heart is to provide a patient with a functional circulatory system while they await a heart transplant or as a long-term solution if a transplant is not possible. It can significantly improve the quality of life for patients with severe heart failure, allowing them to engage in normal daily activities. However, there are several challenges associated with adult artificial hearts. These include the risk of infection, blood clotting, device malfunction, and the need for lifelong anticoagulant medication to prevent clotting. Additionally, the external power source and control unit can limit mobility and require the patient to be connected to a power source at all times. Research and development in the field of adult artificial hearts are ongoing, with the aim of improving the design, reducing complications, and increasing the lifespan of these devices.

The future trends of adult artificial hearts are likely to focus on improving the durability, functionality, and compatibility of these devices. Advancements in materials science and engineering will lead to the development of more durable and long-lasting artificial hearts, reducing the need for frequent replacements and improving patient outcomes. Additionally, advancements in sensor technology and data analytics will enable artificial hearts to better mimic the natural function of the human heart, leading to improved overall performance and reduced risk of complications. Furthermore, research into biocompatible materials and tissue engineering techniques will allow for the development of artificial hearts that are better integrated into the body, reducing the risk of rejection and improving long-term outcomes for patients.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Adult Artificial Heart market?

What factors are driving Adult Artificial Heart market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Adult Artificial Heart market opportunities vary by end market size?

How does Adult Artificial Heart break out by Type, by Application?

This report presents a comprehensive overview of the global Adult Artificial Heart market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Total Artificial Heart
  • Left Ventricular Assist Device
  • Right Ventricular Assist Device
  • Biventricular Assist Device

Segment by Application

  • Heart Transplant Goals
  • Heart Transplant Bridges
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Adult Artificial Heart market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Heart Transplant Goals, Heart Transplant Bridges, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type
Total Artificial HeartLeft Ventricular Assist DeviceRight Ventricular Assist DeviceBiventricular Assist Device
By Application
Heart Transplant GoalsHeart Transplant BridgesOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Total Artificial Heart
  • 3.1.3 Left Ventricular Assist Device
  • 3.1.4 Right Ventricular Assist Device
  • 3.1.5 Biventricular Assist Device
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Heart Transplant Goals
  • 4.1.3 Heart Transplant Bridges
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Abbott
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 SynCardia
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Berlin Heart
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Jarvik Heart
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 CARMAT
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 BiVACOR
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Cleveland Heart
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Abiomed
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 CorWave
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Suzhou Tongxin Medical Equipment Co
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Thoratec Corporation
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Medtronic
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Evaheart, Inc
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 CardioDyme
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How is Adult Artificial Heart defined?
An adult artificial heart is a medical device that is designed to replace a damaged or diseased heart in an adult patient. It is used as a last resort treatment option for individuals who have end-stage heart failure and are not eligible for a heart transplant. The artificial heart is typically made up of two ventricles, which are responsible for pumping blood throughout the body.
How is the Adult Artificial Heart market segmented by type?
By type, the market is segmented into Total Artificial Heart, Left Ventricular Assist Device, Right Ventricular Assist Device and Biventricular Assist Device.
What are the key applications of Adult Artificial Heart?
Key applications covered include Heart Transplant Goals, Heart Transplant Bridges and Others.
Which companies are profiled in the Adult Artificial Heart market report?
Key players profiled include Abbott, SynCardia, Berlin Heart, Jarvik Heart, CARMAT, BiVACOR, Cleveland Heart and Abiomed, among 14 companies covered in total.
What geographies does the Adult Artificial Heart market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Adult Artificial Heart?
What factors are driving Adult Artificial Heart market growth, globally and by region?
What are the main risks and barriers in the Adult Artificial Heart market?
However, there are several challenges associated with adult artificial hearts.
Who should buy the Adult Artificial Heart market report?
The report is intended for manufacturers and solution providers, distributors and end users in Heart Transplant Goals, Heart Transplant Bridges and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Adult Artificial Heart market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.